Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.
Multiple myeloma is the second most common type of blood cancer after leukemia. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma.